Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Health Technology Topic Center

Featured Article

AI
News
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Nate Wade, PharmD.
Videos
03/25/2024

Featuring Nate Wade, PharmD, MBA, BCOP

Featuring Nate Wade, PharmD, MBA, BCO...
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate...
03/25/2024
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
10/24/2023

Brandon Twyford

Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
10/08/2023

Featuring Will Shapiro

Featuring Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
Video preview thumbnail.
Videos
10/02/2023

Featuring Daniel Virnich, MD; Yale Podnos, MD; and Nikhil Buduma

Featuring Daniel Virnich, MD; Yale Po...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The...
10/02/2023
Journal of Clinical Pathways
Video preview image.
Videos
09/22/2023

Featuring Michael Gieske, MD, and Jamie Ries, RN, BSN

Featuring Michael Gieske, MD, and Jam...
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie...
09/22/2023
Journal of Clinical Pathways
Clinical Pathways Forum
09/19/2023
Mishellene McKinney, MHA, RN, OCN—Column Editor
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical Pathways Forum, Suzzette Arnal, PhD, addressed the Forum about precision medicine and how The US Oncology Network has worked to increase precision medicine testing across their organization.
For the May 2023 Clinical...
09/19/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
09/05/2023

Featuring Stephen Edge, MD

Featuring Stephen Edge, MD
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
Video thumbnail screenshot.
Videos
08/30/2023

Featuring Claire Snyder, PhD, and Norah Crossnohere, PhD

Featuring Claire Snyder, PhD, and Nor...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns...
08/30/2023
Journal of Clinical Pathways
James Hamrick, MD, MPH
Interview
03/21/2023
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH,...
03/21/2023
Journal of Clinical Pathways

Newsfeed

AI
News
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
10/24/2023

Brandon Twyford

Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways
News
05/27/2022

Ellen Kurek

Ellen Kurek
Automated alerts providing recommendations in the electronic health record were shown to increase the rate of compliance with such recommendations by 5% to 10%.
Automated alerts providing recommendations in the electronic health record were shown to increase the rate of compliance with such recommendations by 5% to 10%.
Automated alerts providing...
05/27/2022
Journal of Clinical Pathways
News
05/16/2022

Ellen Kurek

Ellen Kurek
Researchers developed a whole-slide image analyzer powered by artificial intelligence that could detect three immune phenotypes that correlated with treatment outcomes to immune checkpoint inhibitors among patients with NSCLC.
Researchers developed a whole-slide image analyzer powered by artificial intelligence that could detect three immune phenotypes that correlated with treatment outcomes to immune checkpoint inhibitors among patients with NSCLC.
Researchers developed a...
05/16/2022
Journal of Clinical Pathways
News
04/14/2022

Ellen Kurek

Ellen Kurek
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate...
04/14/2022
Journal of Clinical Pathways
News
09/21/2021
Researchers developed an interactive visualization tool for kidney cancer with the potential to facilitate shared decision-making between patients and providers.
Researchers developed an interactive visualization tool for kidney cancer with the potential to facilitate shared decision-making between patients and providers.
Researchers developed an...
09/21/2021
Journal of Clinical Pathways
News
08/31/2021
A recent article detailing a cyberattack on the University of Vermont Health Network discusses the impact the attack had on cancer care delivery and offers advice on oncology practices that can be implemented to lessen the impact of a...
A recent article detailing a cyberattack on the University of Vermont Health Network discusses the impact the attack had on cancer care delivery and offers advice on oncology practices that can be implemented to lessen the impact of a...
A recent article detailing a...
08/31/2021
Journal of Clinical Pathways
News
08/25/2021
An expert panel developed standards and guidance for oncology clinicians who are utilizing telehealth for their patients.
An expert panel developed standards and guidance for oncology clinicians who are utilizing telehealth for their patients.
An expert panel developed...
08/25/2021
Journal of Clinical Pathways
News
07/29/2021
The utilization of telehealth in oncology does not lead to worse efficiency or outcomes for patients, when compared with in-person care.
The utilization of telehealth in oncology does not lead to worse efficiency or outcomes for patients, when compared with in-person care.
The utilization of telehealth in...
07/29/2021
Journal of Clinical Pathways
News
05/15/2024
Grace Taylor, MS, MA
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review...
05/15/2024
Journal of Clinical Pathways
News
05/10/2024
Grace Taylor, MS, MA
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the...
05/10/2024
Journal of Clinical Pathways
News
05/08/2024
Grace Taylor, MS, MA
MorphoSys’ $2.9 billion acquisition deal with Novartis may be in jeopardy due to reports regarding safety problems with its investigational myelofibrosis drug pelabresib.
MorphoSys’ $2.9 billion acquisition deal with Novartis may be in jeopardy due to reports regarding safety problems with its investigational myelofibrosis drug pelabresib.
MorphoSys’ $2.9 billion...
05/08/2024
Journal of Clinical Pathways
News
04/22/2024

Grace Taylor

Grace Taylor
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help...
04/22/2024
Journal of Clinical Pathways
News
04/12/2024

Grace Taylor

Grace Taylor
A recent study by Farrukh Awan, MD, and colleagues estimated the total lifetime cost of treating patients with chronic lymphocytic leukemia in the US.
A recent study by Farrukh Awan, MD, and colleagues estimated the total lifetime cost of treating patients with chronic lymphocytic leukemia in the US.
A recent study by Farrukh Awan,...
04/12/2024
Journal of Clinical Pathways
News
04/11/2024

Brandon Twyford

Brandon Twyford
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024...
04/11/2024
Journal of Clinical Pathways
News
04/11/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
04/11/2024
Journal of Clinical Pathways
AI
News
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
News
03/26/2024

Grace Taylor

Grace Taylor
A group of researchers examined disease progression for patients with low-risk myelofibrosis participating in the prospective observational MOST study.
A group of researchers examined disease progression for patients with low-risk myelofibrosis participating in the prospective observational MOST study.
A group of researchers examined...
03/26/2024
Journal of Clinical Pathways
News
03/22/2024

Jordan Kadish

Jordan Kadish
According to findings from the phase 2 REVIVE trial, rusfertide treatment demonstrated improved responses and decreased erythrocytosis among patients with polycythemia vera.
According to findings from the phase 2 REVIVE trial, rusfertide treatment demonstrated improved responses and decreased erythrocytosis among patients with polycythemia vera.
According to findings from the...
03/22/2024
Oncology

Conference Coverage

AI
News
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Nate Wade, PharmD.
Videos
03/25/2024

Featuring Nate Wade, PharmD, MBA, BCOP

Featuring Nate Wade, PharmD, MBA, BCO...
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate...
03/25/2024
Journal of Clinical Pathways
Amy Valley and the AI panel from CPC+CBEx.
News
10/24/2023

Brandon Twyford

Brandon Twyford
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care: Separating Fact from Fiction" session at CPC & CBEx 2023, Ira Klein, MD, Amy Valley, PharmD, James Hamrick, MD, Ed Rodgers, Will Shapiro, and Zachary Taft, MBA, delved into the present applications and future...
During the “AI in Cancer Care:...
10/24/2023
Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
10/08/2023

Featuring Will Shapiro

Featuring Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
James Hamrick, MD, MPH
Interview
03/21/2023
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH,...
03/21/2023
Journal of Clinical Pathways
Rebecca Maniago, PharmdD, BCOP
Interview
03/20/2023
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP,...
03/20/2023
Journal of Clinical Pathways
Matthew Lunning, DO, FACP
Videos
10/27/2022
Matthew Lunning, DO, FACP, discusses the expansion of telehealth during the “COVID era,” highlighting the importance of face-to-face encounters between patients and health care providers, and suggesting ways to successfully meet this demand...
Matthew Lunning, DO, FACP, discusses the expansion of telehealth during the “COVID era,” highlighting the importance of face-to-face encounters between patients and health care providers, and suggesting ways to successfully meet this demand...
Matthew Lunning, DO, FACP,...
10/27/2022
Journal of Clinical Pathways
Conference Coverage
09/30/2022

Craig Ostroff

Craig Ostroff
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at academic medical centers have shown an improvement in clinical outcomes when utilizing patient-reported outcome-based symptom management solutions, according to a presentation at the 2022 ASCO Quality Care...
Randomized controlled trials at...
09/30/2022
Journal of Clinical Pathways
Conference Coverage
03/05/2022

Marta Rybczynski

Marta Rybczynski
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought on a panel showcasing products and services that improve clinical making and patient support, featuring platforms from Elsevier, GE Medical, Flatiron Assist,...
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought on a panel showcasing products and services that improve clinical making and patient support, featuring platforms from Elsevier, GE Medical, Flatiron Assist,...
A session at the ACCC 48th...
03/05/2022
Journal of Clinical Pathways
Lalan Wilfong, MD
Videos
05/16/2024
Lalan Wilfong, MD
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his...
05/16/2024
Journal of Clinical Pathways
News
05/10/2024
Grace Taylor, MS, MA
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the...
05/10/2024
Journal of Clinical Pathways
Julia Morton
Videos
05/01/2024
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice...
05/01/2024
Journal of Clinical Pathways
Michael Serzan, MD
Videos
04/24/2024

Featuring Michael Serzan, MD, Dana-Farber Cancer Institute

Featuring Michael Serzan, MD, Dana-Fa...
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights...
04/24/2024
Journal of Clinical Pathways
Conference Coverage
04/12/2024

Grace Taylor

Grace Taylor
A group of health care industry experts recently shared legislative updates from Washington, DC, impacting oncology at the 2024 Community Oncology Conference.
A group of health care industry experts recently shared legislative updates from Washington, DC, impacting oncology at the 2024 Community Oncology Conference.
A group of health care industry...
04/12/2024
Journal of Clinical Pathways
Rose Gerber, MS
Videos
04/12/2024

Featuring Rose Gerber, MS

Featuring Rose Gerber, MS
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer...
04/12/2024
Journal of Clinical Pathways
News
04/11/2024

Brandon Twyford

Brandon Twyford
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024...
04/11/2024
Journal of Clinical Pathways
News
04/11/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
04/11/2024
Journal of Clinical Pathways
AI
News
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
John Allan, MD, Weill Cornell Medicine
Conference Coverage
04/10/2024

Featuring John Allan, MD

Featuring John Allan, MD
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use...
04/10/2024
Lymphoma, Leukemia & Myeloma Network

Expert Insights

Robert Stillman, MA, RN
Videos
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Nate Wade, PharmD.
Videos
03/25/2024

Featuring Nate Wade, PharmD, MBA, BCOP

Featuring Nate Wade, PharmD, MBA, BCO...
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate Wade, PharmD, MBA, BCOP, associate director for clinical oncology at Flatiron Health, talks about the role of electronic health records in precision medicine.
In this video interview, Nate...
03/25/2024
Journal of Clinical Pathways
Will Shapiro, Flatiron Health
Conference Coverage
10/08/2023

Featuring Will Shapiro

Featuring Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
Video preview thumbnail.
Videos
10/02/2023

Featuring Daniel Virnich, MD; Yale Podnos, MD; and Nikhil Buduma

Featuring Daniel Virnich, MD; Yale Po...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The Oncology Institute, Yale Podnos, MD, CMO of The Oncology Institute, and Nikhil Buduma, co-founder and chief scientist for Ambience Healthcare, discuss the benefits, challenges, and considerations for...
Daniel Virnich, MD, CEO of The...
10/02/2023
Journal of Clinical Pathways
Video preview image.
Videos
09/22/2023

Featuring Michael Gieske, MD, and Jamie Ries, RN, BSN

Featuring Michael Gieske, MD, and Jam...
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie...
09/22/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
09/05/2023

Featuring Stephen Edge, MD

Featuring Stephen Edge, MD
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
Video thumbnail screenshot.
Videos
08/30/2023

Featuring Claire Snyder, PhD, and Norah Crossnohere, PhD

Featuring Claire Snyder, PhD, and Nor...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns Hopkins Schools of Medicine and Public Health, and Norah Crossnohere, PhD, the Ohio State University College of Medicine, discuss their work on implementing patient-reported outcome measures into cancer care, and how...
Claire Snyder, PhD, Johns...
08/30/2023
Journal of Clinical Pathways
James Hamrick, MD, MPH
Interview
03/21/2023
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH,...
03/21/2023
Journal of Clinical Pathways
Rebecca Maniago, PharmdD, BCOP
Interview
03/20/2023
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP,...
03/20/2023
Journal of Clinical Pathways
Michael Kolodziej, MD
Videos
11/17/2022
Michael Kolodziej, MD, Advisor, Canopy, discusses at the 2022 Oncology Clinical Pathways Congress how electronic patient-reported outcomes and electronic engagement with patients can aid improve outcomes.
Michael Kolodziej, MD, Advisor, Canopy, discusses at the 2022 Oncology Clinical Pathways Congress how electronic patient-reported outcomes and electronic engagement with patients can aid improve outcomes.
Michael Kolodziej, MD, Advisor,...
11/17/2022
Journal of Clinical Pathways
Lalan Wilfong, MD
Videos
05/16/2024
Lalan Wilfong, MD
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his...
05/16/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
05/06/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part...
05/06/2024
Cancer Care Business Exchange
Julia Morton
Videos
05/01/2024
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice...
05/01/2024
Journal of Clinical Pathways
JCP Flatiron Roundtable 1 Thumbnail
Videos
05/01/2024

Featuring Gordon Kuntz; Jeremy Drainville; James Hamrick, MD; Larry Shulman, MD; Bryan Loy, MD

Featuring Gordon Kuntz; Jeremy Drainv...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants...
05/01/2024
Journal of Clinical Pathways
Michael Serzan, MD
Videos
04/24/2024

Featuring Michael Serzan, MD, Dana-Farber Cancer Institute

Featuring Michael Serzan, MD, Dana-Fa...
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights...
04/24/2024
Journal of Clinical Pathways
Kerry Rogers, MD
Interview
04/19/2024

Featuring Kerry Rogers, MD, The Ohio State University

Featuring Kerry Rogers, MD, The Ohio ...
Kerry Rogers, MD, The Ohio State University, discusses results from her study on how Bruton tyrosine kinase (BTK) inhibitors ibrutinib and venetoclax could help eliminate molecular resistance in patients with CLL who have resistance mutations.
Kerry Rogers, MD, The Ohio State University, discusses results from her study on how Bruton tyrosine kinase (BTK) inhibitors ibrutinib and venetoclax could help eliminate molecular resistance in patients with CLL who have resistance mutations.
Kerry Rogers, MD, The Ohio State...
04/19/2024
Journal of Clinical Pathways
Rose Gerber, MS
Videos
04/12/2024

Featuring Rose Gerber, MS

Featuring Rose Gerber, MS
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer...
04/12/2024
Journal of Clinical Pathways
John Allan, MD, Weill Cornell Medicine
Conference Coverage
04/10/2024

Featuring John Allan, MD

Featuring John Allan, MD
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use...
04/10/2024
Lymphoma, Leukemia & Myeloma Network
Erin Fox, PharmD
Videos
04/08/2024

Featuring Erin Fox, PharmD

Featuring Erin Fox, PharmD
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps...
04/08/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement